Informações:
Falhas:
ID
44018
Descrição
Study ID: 101468/207 Clinical Study ID: SKF-101468/207 Study Title:A double-blind, randomized, placebo-controlled, parallel-group study to investigate the tolerability of a dose-escalating regimen of ropinirole in patients suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome Dose Level 1 (Day 1)
Palavras-chave
Versões (2)
- 04/08/2017 04/08/2017 -
- 20/09/2021 20/09/2021 -
Titular dos direitos
GlaxoSmithKline
Transferido a
20 de setembro de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC-ND 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Dose Level 1 GSK Ropinirole Restless Legs Syndrome 101468
Dose Level 1 GSK Ropinirole Restless Legs Syndrome 101468
- StudyEvent: ODM
Similar models
Dose Level 1 GSK Ropinirole Restless Legs Syndrome 101468
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
text
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
C0019994 (UMLS CUI [1,2])
Visit Day
Item
Visit Day
date
C2827038 (UMLS CUI [1])
Item Group
Predose Checklist - Instructions: Please mark appropriateanswer to the following questions. If the answer to all the questions is YES then dosing may proceed.
C0439565 (UMLS CUI-1)
C1707357 (UMLS CUI-2)
C1707357 (UMLS CUI-2)
Date of last RLS medication
Item
1. Has the patient washed out from their previous RLS medication for the appropriate length of time (DAY 1)?
boolean
C4029433 (UMLS CUI [1,1])
C0035258 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,2])
Last Alcohol Consumption
Item
2. Has the patient refrained from consuming alcohol from midnight prior to the clinic visit?
boolean
C0001948 (UMLS CUI [1,1])
C1517741 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
Alcohol consumption
Item
3. Has the patient limited their daily consumption to no more than 3 units for men and 2 units for women? (1 unit is equivalent to 1 beer, 1.5 ounces of hard liquor or 1 small glass of wine.)
boolean
C0001948 (UMLS CUI [1])
Strenuous Exercise
Item
4. Has the patient refrained from strenuous exercise (outside of normal routine) from 24 hours before the clinic visit?
boolean
C1514989 (UMLS CUI [1])
Smoking Status
Item
5. Has the patient maintained their normal smoking practice?
boolean
C1519386 (UMLS CUI [1])
Caffeinated beverage
Item
6. Has the patient refrained from caffeine-containing beverages from 12 noon on the day of the clinic visit?
boolean
C0678438 (UMLS CUI [1])
OTC or herbal remedies
Item
7. Has the patient refrained from taking other medication (OTC or herbal remedies) for 48 hours prior to the clinic visit? Patients who have taken OTC medication may still be able to continue in the study, if, in the opinion of the Investigator, the medication received will not interfere with the study procedures or compromise safety.
boolean
C0013231 (UMLS CUI [1])
C0025125 (UMLS CUI [2])
C0025125 (UMLS CUI [2])
Concomitant Medication
Item
8. For the concomitant medication which are CYP1A2 inducers, substrated or inhibitors, has the patient kept the dose constant? (this includes women taking hormone replacement therapy or oestrogen containing medications)
boolean
C2347852 (UMLS CUI [1])
RLS Rating Scale
Item
RLS Rating Scale
text
C0681889 (UMLS CUI [1,1])
C0035258 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,2])
Prior Medication
Item
Has the subject taken any medication within 1 week PRIOR to the first dose of study medication?
boolean
C2826257 (UMLS CUI [1])
Drug name
Item
Drug Name (Trade Name Preferred)
text
C0013227 (UMLS CUI [1])
Dose
Item
SINGLE Dose/Unit (e.g. 500mg)
text
C3174092 (UMLS CUI [1])
Medication Frequency
Item
Frequency of this (e.g. BID, PRN)
text
C3476109 (UMLS CUI [1])
Administration Route
Item
Route
text
C0013153 (UMLS CUI [1])
Duration of Therapy
Item
Duration of Therapy (e.g. 6 years)
text
C0444921 (UMLS CUI [1])
End Date
Item
End Date
date
C0806020 (UMLS CUI [1])
Continuing
Item
Continuing at end of study?
boolean
C1553904 (UMLS CUI [1])
Pregnancy Test
Item
Was a pregnancy test carried out?
boolean
C0032976 (UMLS CUI [1])
Reason for Pregnancy Test
Item
If 'NO', please specify reason
text
C0392360 (UMLS CUI [1,1])
C0032976 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
Date of Pregnany Test
Item
If ´YES´, please indicate date of result:
date
C0011008 (UMLS CUI [1,1])
C0032976 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
CL Item
Negative (Negative)
CL Item
Positive (Positive)
Item Group
Vital Signs - Instructions: Semi-supine recordings must be made after the patient has been resting semi-supine for at least 10 min & erect measurments will be taken after the patients has been erect for a period of 1 min. Three sets of stable semi-supine and errect vital signs must be recorded pre-dose with the patient resting fro 10 min semi-supine between each set. In this instance 'stable' is defined at all measurements being within 15 mmHg of the lowest measurements for each and every parameter e.g. semi-supine diastolic. - The blood pressure cuff must be placed on the same arm throughout the study. - The same study nurse/operator should conduct all the blood pressure measurements for each clinic visit.
C0518766 (UMLS CUI-1)
C0439565 (UMLS CUI-2)
C0439565 (UMLS CUI-2)
Date of Examination: Pre-Dose
Item
Date
date
C2826643 (UMLS CUI [1,1])
C0439565 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,2])
Time of Examination: Pre-Dose
Item
Time
time
C0040223 (UMLS CUI [1,1])
C0430022 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
C0430022 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
Semi-supine Systolic Blood Pressure: Pre-Dose
Item
Semi-supine Blood Pressure: Systolic
float
C0522019 (UMLS CUI [1,1])
C0871470 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
C0871470 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
Semi-supine Diastolic Blood Pressure: Pre-Dose
Item
Semi-supine Blood Pressure: Diastolic
float
C0522019 (UMLS CUI [1,1])
C0428883 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
C0428883 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
Semi-supine Heart Rate: Pre-Dose
Item
Semi-supine Heart Rate
float
C0522019 (UMLS CUI [1,1])
C0018810 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
C0018810 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
Erect Systolic Blood Pressure: Pre-Dose
Item
Erect Blood Pressure: Systolic
float
C0522014 (UMLS CUI [1,1])
C0871470 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
C0871470 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
Erect Diastolic Blood Pressure: Pre-Dose
Item
Erect Blood Pressure: Diastolic
float
C0522014 (UMLS CUI [1,1])
C0428883 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
C0428883 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,3])
Erect Heart Rate: Pre-Dose
Item
Erect Heart Rate
float
C0522014 (UMLS CUI [1,1])
C0018810 (UMLS CUI [1,2])
C0018810 (UMLS CUI [1,2])
Item Group
Baseline Signs and Symptoms - Please note any SERIOUS events should be recorded on this page, but on the Serious Adverse Event pages provided. Record any Baseline events (using standard medical terminology) observed or elicited by the following direct question to subject: "How do you feel?" Provide the diagnosis, NOT symptoms where possible. (One baseline event per column)
C0037088 (UMLS CUI-1)
No Baseline Signs and Symptoms
Item
If no baseline events experienced, please mark box and sign from below.
boolean
C0037088 (UMLS CUI [1,1])
C1518422 (UMLS CUI [1,2])
C1518422 (UMLS CUI [1,2])
Baseline Signs and Symptoms
Item
Baseline Signs and Symptoms
text
C0037088 (UMLS CUI [1])
Date of Onset
Item
Onset Date
date
C0574845 (UMLS CUI [1])
Time of Onset
Item
Onset Time
time
C0449244 (UMLS CUI [1])
End Date of Baseline Signs and Symptoms
Item
End Date (If ongoing please leave blank)
date
C0806020 (UMLS CUI [1,1])
C0037088 (UMLS CUI [1,2])
C0037088 (UMLS CUI [1,2])
End Time of Baseline Signs and Symptoms
Item
End Time (If ongoing please leave blank)
time
C1522314 (UMLS CUI [1,1])
C0037088 (UMLS CUI [1,2])
C0037088 (UMLS CUI [1,2])
CL Item
Resolved (Resolved)
CL Item
Moderate (Moderate)
CL Item
Died* (Died*)
CL Item
Intermittent (Intermittent)
CL Item
Constant (Constant)
Number of Episodes
Item
Event Course If Intermittent, specify No. of episodes
integer
C4086638 (UMLS CUI [1])
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
Item
Relationship to study procedures performed prior to randomisation
text
C0439849 (UMLS CUI [1])
CL Item
Not related (Not related)
CL Item
Unlikely (Unlikely)
CL Item
Suspected (reasonable possibility) (Suspected (reasonable possibility))
CL Item
Probable (Probable)
Corrective Therapy
Item
Corrective Therapy (If 'YES', Please record on Prior Medication form)
boolean
C0087111 (UMLS CUI [1])
Withdrawal
Item
Was subject withdrawn due to this event?
boolean
C2349954 (UMLS CUI [1])
Afternoon meal
Item
Was afternoon meal/snack eaten before dosing?
boolean
C0439550 (UMLS CUI [1,1])
C1998602 (UMLS CUI [1,2])
C1998602 (UMLS CUI [1,2])
Date of last food intake
Item
Meal finish date:
date
C0578574 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Time of last food intake
Item
Time of last food intake
time
C0578574 (UMLS CUI [1])
Date of Dosing
Item
Date of dosing
date
C0178602 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Time of Dosing
Item
Time of dosing
time
C0178602 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
Container Number
Item
Please record the following details from the bottle: Container Number
text
C0180098 (UMLS CUI [1])
Label
Item
Please remove the label from the medication carton and attach below:
text
C0013191 (UMLS CUI [1])
Dose Level
Item
Dose Level
text
C0178602 (UMLS CUI [1])
Doctor's Name
Item
Dose checked and administered by:
text
C0027365 (UMLS CUI [1,1])
C0031831 (UMLS CUI [1,2])
C0031831 (UMLS CUI [1,2])
Item Group
Vital Signs Instructions: For each set, semi-supine measurements will be made after the patient has been resting semi-supine for at least 10 min & erect measurements will be taken after the patients has been erect for a period of 1 min. - The blood pressure cuff must be placed on same arm throughout the study. - The same study nurse/operator should conduct all the blood pressure measurements for each clinic visit.
C0518766 (UMLS CUI-1)
C0439568 (UMLS CUI-2)
C0439568 (UMLS CUI-2)
Item
Study Time: Repeat at:
text
C2348563 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
CL Item
+ 0.5 hrs (+ 0.5 hrs)
CL Item
+ 1 hrs (+ 1 hrs)
CL Item
+ 1.5 hrs (+ 1.5 hrs)
CL Item
+ 2 hrs (+ 2 hrs)
CL Item
+ 3 hrs (+ 3 hrs)
CL Item
+ 4 hrs (+ 4 hrs)
CL Item
+ 5 hrs (+ 5 hrs)
CL Item
+ 6 hrs (+ 6 hrs)
Date of Examination: Post-Dose
Item
Date
date
C2826643 (UMLS CUI [1,1])
C0439568 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,2])
Time of Examination: Post-Dose
Item
Time
time
C0040223 (UMLS CUI [1,1])
C0043299 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C0043299 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
Semi-supine Systolic Blood Pressure: Post-Dose
Item
Semi-supine Blood Pressure: Systolic
float
C0522019 (UMLS CUI [1,1])
C0871470 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C0871470 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
Semi-supine Diastolic Blood Pressure: Post-Dose
Item
Semi-supine Blood Pressure: Diastolic
float
C0522019 (UMLS CUI [1,1])
C0428883 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C0428883 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
Semi-supine Heart Rate: Post-Dose
Item
Semi-supine Heart Rate
float
C0522019 (UMLS CUI [1,1])
C0018810 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C0018810 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
Erect Systolic Blood Pressure: Post-Dose
Item
Erect Blood Pressure: Systolic
float
C0522014 (UMLS CUI [1,1])
C0871470 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C0871470 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
Erect Diastolic Blood Pressure: Post-Dose
Item
Erect Blood Pressure: Diastolic
boolean
C0522014 (UMLS CUI [1,1])
C0428883 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C0428883 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
Erect Heart Rate: Post-Dose
Item
Erect Heart Rate
float
C0522014 (UMLS CUI [1,1])
C0018810 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
C0018810 (UMLS CUI [1,2])
C0439568 (UMLS CUI [1,3])
Item Group
Adverse Event - Record any Adverse event (using standard medical terminology) observed or elicited as a result of spontaneous reporting by patient "How are you feeling" (pre-dose) and at subsequent schedules intervals post-dose: "Since you were last asked have you felt unwell or different from usual?" Provide the diagnosis NOT symptoms where possible.
C0877248 (UMLS CUI-1)
CL Item
+ 2 hrs (+ 2 hrs)
CL Item
+ 6 hrs (+ 6 hrs)
CL Item
Next Day (by telephone) (Next Day (by telephone))
Adverse Event
Item
Any Adverse Events?
boolean
C0877248 (UMLS CUI [1])
Item
In the Investigator's opinion, is it safe for the patient to continue dosing at home?
text
Code List
In the Investigator's opinion, is it safe for the patient to continue dosing at home?
CL Item
Yes (Y)
CL Item
No (N)
Item
If 'No', select a dosing strategy from options below and tick the relevant box:
text
Code List
If 'No', select a dosing strategy from options below and tick the relevant box:
CL Item
TRY AGAIN (TRY AGAIN)
CL Item
MTD DETERMINED (MTD DETERMINED)